Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03532295
Title INCMGA00012 and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

glioblastoma

gliosarcoma

Therapies

Bevacizumab + Epacadostat + Radiotherapy + Retifanlimab

Bevacizumab + Radiotherapy + Retifanlimab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.